B. Dubois, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol, vol.6, pp.734-746, 2007.

S. W. Scheff, D. L. Sparks, and D. A. Price, Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease, Dementia, vol.7, pp.226-232, 1996.

J. Del-valle, Dendritic spine abnormalities in hippocampal CA1 pyramidal neurons underlying memory deficits in the SAMP8 mouse model of Alzheimer's disease, J. Alzheimers Dis, vol.32, pp.233-240, 2012.

C. Casas, Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model, Am. J. Pathol, vol.165, pp.1289-1300, 2004.

G. A. Kerchner, Hippocampal CA1 apical neuropil atrophy and memory performance in Alzheimer's disease, Neuroimage, vol.63, pp.194-202, 2012.

G. Aicardi, Age-related impairment of visual recognition memory correlates with impaired synaptic distribution of GluA2 and protein kinase M? in the dentate gyrus, Rejuvenation Res, vol.15, pp.530-533, 2012.

M. Na, Prognostic value of CA4/DG volumetry with 3T magnetic resonance imaging on postoperative outcome of epilepsy patients with dentate gyrus pathology, Epilepsy Res, vol.108, pp.1315-1325, 2014.

K. Honjo, S. E. Black, and N. P. Verhoeff, Alzheimer's disease, cerebrovascular disease, and the ? -amyloid cascade. Can, J. Neurol. Sci, vol.39, pp.712-728, 2012.

C. Schmidt, A. Karch, C. Korth, and I. Zerr, On the issue of transmissibility of Alzheimer disease: a critical review, Prion, vol.6, pp.447-452, 2012.

T. Kang, Large-scale analysis of posttranslational modifications in the hippocampus of patients with Alzheimer's disease using pI shift and label-free quantification without enrichment, Anal. Bioanal. Chem, vol.406, pp.5433-5446, 2014.

M. Polydoro, Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model, Acta Neuropathol, vol.127, pp.257-270, 2014.

H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta neuropathol, vol.82, pp.239-259, 1991.

H. Hampel, Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020, Biochem. Pharmacol, vol.88, pp.426-449, 2014.

K. H. Kwon, Chromosome 11-centric human proteome analysis of human brain hippocampus tissue, J. Proteome Res, vol.12, pp.97-105, 2013.

P. Picotti, B. Bodenmiller, L. N. Mueller, B. Domon, and R. Aebersold, Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics, Cell, vol.138, pp.795-806, 2009.

K. J. Boggio, Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impact, Expert Rev Proteomics, vol.8, pp.591-604, 2011.

F. Deutskens, J. Yang, and R. M. Caprioli, High spatial resolution imaging mass spectrometry and classical histology on a single tissue section, J. Mass Spectrom, vol.46, pp.568-571, 2011.

A. Minelli, PCLO gene: its role in vulnerability to major depressive disorder, J. Affect. Disord, vol.139, pp.250-255, 2012.

S. D. Fenster, Piccolo, a presynaptic zinc finger protein structurally related to bassoon, Neuron, vol.25, pp.203-214, 2000.

C. L. Waites, Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation, EMBO J, vol.32, pp.954-969, 2013.

M. Guglielmotto, Abeta1-42-mediated down-regulation of Uch-L1 is dependent on NF-kappaB activation and impaired BACE1 lysosomal degradation, Aging cell, vol.11, pp.834-844, 2012.

G. E. Gibson, L. C. Park, H. Zhang, S. Sorbi, and N. Y. Calingasan, Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits, Ann. N. Y. Acad. Sci, vol.893, pp.79-94, 1999.

Q. Shi and G. E. Gibson, Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743a, J. Neurochem, vol.118, pp.440-448, 2011.

R. Murr, Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks, Nat. Cell Biol, vol.8, pp.91-99, 2006.

M. Stante, Fe65 is required for Tip60-directed histone H4 acetylation at DNA strand breaks, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.5093-5098, 2009.

I. Mateo, 14-3-3 zeta and tau genes interactively decrease Alzheimer's disease risk, Dement. Geriatr. Cogn. Disord, vol.25, pp.317-320, 2008.

J. A. Miller, M. C. Oldham, and D. H. Geschwind, A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging, J. Neurosci, vol.28, pp.1410-1420, 2008.

J. Choi, Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases, J. Biol. Chem, vol.279, pp.13256-13264, 2004.

M. T. Gentile, Mechanisms of soluble beta-amyloid impairment of endothelial function, J. Biol. Chem, vol.279, pp.48135-48142, 2004.

M. P. Soutar, P. Thornhill, A. R. Cole, and C. Sutherland, Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development?, Current Alzheimer research, vol.6, pp.269-278, 2009.

, Scientific RepoRts |, vol.5

G. Froyen, Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation, Am J Hum Genet, vol.82, pp.432-443, 2008.

P. Bottger, Distribution of Na/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain, J Comp Neurol, vol.519, pp.376-404, 2011.

M. J. Martínez-lópez, Mouse neuron navigator 1, a novel microtubule-associated protein involved in neuronal migration, Mol. Cell Neurosci, vol.28, pp.599-612, 2005.

P. D. Muley, The atRA-responsive gene neuron navigator 2 functions in neurite outgrowth and axonal elongation, Dev. Neurobiol, vol.68, pp.1441-1453, 2008.

M. Shioya, Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3, Neuropathol. Appl. Neurobiol, vol.36, pp.320-330, 2010.

E. Carlsson, Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis, Genes Chromosomes Cancer, vol.52, pp.191-201, 2013.

I. Hong, Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology, J. Alzheimers Dis, vol.36, pp.321-334, 2013.

E. Steen, Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?, J. Alzheimers Dis, vol.7, pp.63-80, 2005.

E. Van-exel, Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: findings from a family study, Neurobiol. Aging, vol.35, 2014.

E. R. Vardy, Increased circulating insulin-like growth factor-1 in late-onset Alzheimer's disease, J. Alzheimers Dis, vol.12, pp.285-290, 2007.

L. Puglielli, Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit?, Neurobiol. Aging, vol.29, pp.795-811, 2008.

K. Marosi and M. P. Mattson, BDNF mediates adaptive brain and body responses to energetic challenges, Trends Endocrinol. Metab, vol.25, pp.89-98, 2014.

A. H. Nagahara, Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice, J. Neurosci, vol.33, pp.15596-15602, 2013.

M. K. Shin, Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brainderived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques, Neurobiol. Aging, vol.35, pp.990-1001, 2014.

J. C. Belrose, R. Masoudi, B. Michalski, and M. Fahnestock, Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies, Neurobiol. Aging, vol.35, pp.926-933, 2014.

I. Ferrer and R. Blanco, N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease, Brain Res. Mol. Brain Res, vol.77, pp.270-276, 2000.

F. Silvestris, Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms

, Ann. Ital. Med. Int, vol.10, pp.7-13, 1995.

H. Akl, HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation, Leukemia, vol.21, pp.788-796, 2007.

I. Bezprozvanny, Calcium signaling and neurodegenerative diseases, Trends Mol. Med, vol.15, pp.89-100, 2009.

N. Prevarskaya, R. Skryma, and Y. Shuba, Targeting Ca 2+ transport in cancer: close reality or long perspective?, Expert Opin. Ther. Targets, vol.17, pp.225-241, 2013.

A. Galat and J. Bua, Molecular aspects of cyclophilins mediating therapeutic actions of their ligands, Cell. Mol. Life Sci, vol.67, pp.3467-3488, 2010.

K. Matsuura, H. Kabuto, H. Makino, and N. Ogawa, Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain, Brain Res, vol.733, pp.101-104, 1996.

R. Sinigaglia-coimbra, E. A. Cavalheiro, and C. Coimbra, Protective effect of systemic treatment with cyclosporine A after global ischemia in rats, J. Neurol. Sci, pp.273-276, 2002.

Q. S. Chen, W. Z. Wei, T. Shimahara, and C. W. Xie, Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus, Neurobiol. Learn. Mem, vol.77, pp.354-371, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00201234

E. Gagyi, Decreased oligodendrocyte nuclear diameter in Alzheimer's disease and Lewy body dementia, Brain Pathol, vol.22, pp.803-810, 2012.

T. G. Beach, The Sun Health Research Institute Brain Donation Program: description and experience, Cell Tissue Bank, vol.9, pp.229-245, 1987.

C. M. Hulette, Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience, Arch. Pathol. Lab. Med, vol.121, pp.615-618, 1997.

T. G. Beach, Alzheimer's disease and the "Valley Of Death": not enough guidance from human brain tissue?, J. Alzheimers Dis, vol.33, pp.219-233, 2013.

M. S. García-ayllón, CSF Presenilin-1 complexes are increased in Alzheimer's disease, Acta Neuropathol Commun, vol.1, p.46, 2013.

R. J. Kandimalla, CSF p-Tau levels in the prediction of Alzheimer's disease, Biol. Open, vol.2, pp.1119-1124, 2013.

H. M. Kim, Inhibitory effect of tianeptine on catagen induction in alopecia areata-like lesions induced by ultrasonic wave stress in mice, Clin. Exp. Dermatol, vol.38, pp.758-767, 2013.

M. El-ayed, MALDI imaging mass spectrometry in ovarian cancer for tracking, identifying, and validating biomarkers, Med. Sci. Monit, vol.16, pp.233-245, 2010.

Y. Benjamini and Y. Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. R. Statist. Soc. B, vol.57, pp.289-300, 1995.